What drives AYA.AX stock price today?

AYA.AX stock moves today on lighter volume and profit-taking after recent gains. Key drivers are adoption news for Artrya's AI tool, liquidity changes, and near-term earnings expectations ahead of 24 Feb 2026.

What is Meyka AI's 12-month forecast for AYA.AX stock?

Meyka AI's forecast model projects AYA.AX stock at **A$7.90** in 12 months. That implies about **141.56%** upside from **A$3.27**. Forecasts are model projections and not guarantees.

Is AYA.AX stock a buy for AI-focused portfolios?

AYA.AX stock fits AI healthcare themes but carries execution risk. Meyka grades it **B (HOLD)**. Consider position sizing and monitor clinical adoption and cash burn before allocating significant weight.

When is the next AYA.AX earnings release?

Artrya lists its next earnings announcement for **24 Feb 2026**. Investors should watch revenue guidance, adoption metrics for Salix, and any cash runway commentary.

AU Stocks

AYA.AX stock A$3.27 pre-market 07 Feb 2026: AI diagnostics growth remains the core insight

ByDanny Kontos February 7, 2026February 7, 2026

AYA.AX stock trades at A$3.27 in ASX pre-market on 07 Feb 2026, down -3.25% from yesterday. This move follows a short-term pullback from a 52-week high of A$5.24 and sits above the 200-day average of A$2.34. Investors focused on AI in healthcare should note Artrya Limited reports EPS -0.17 and a market cap near A$370556400.00. We use price, volumes and sector context to link recent trading to growth forecasts and the upcoming earnings date on 24 Feb 2026.